Clinical Trials Browser

Phase 1 × Neuroblastoma × Bortezomib × Clear all

NCT00644696 2017-07-06

Study of Irinotecan and Bortezomib in Children With Recurrent/Refractory Neuroblastoma

Phase 1 Completed

Neuroblastoma